Cardlytics CEO Scott Grimes On Ushering Company Through An IPO
Last week, Atlanta-based Cardlytics (CDLX) rang the NASDAQ bell to announce the pricing of its public common stock offering of 5,400,000 shares at $13 per share to raise $70.2 million before underwriting discounts and commissions. Prior to the IPO, Cardlytics had secured over $200 million in